To our knowledge, cytokines have been assessed (e.g., IL-1β, TNF-α, and IL-6) in AD patients and compared to controls or other disease groups, such as vascular dementia or cerebrovascular disease, but typically only in cross-sectional or observational studies and not clinical trials [26,27]. This evidence concerns the gene IL6 and cerebrovascular disorder.